A Multicenter, Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Bimekizumab in the Treatment of Subjects with Active Psoriatic Arthritis

  • Antony, Anna (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/19/CALHN/118
NMA SSA Reference Number: SSA/55056/MonH-2019-192097(v3)
Monash Health Reference: RES-19-0000-810X
Effective start/end date21/11/1920/11/24


  • clinical trial
  • phase 3 study
  • psoriatic arthritis
  • treatment efficacy
  • treatment safety